H. R. 5226
IN THE HOUSE OF REPRESENTATIVES
July 28, 2014
Mr. Perry (for himself, Mr. Rohrabacher, Mr. Cohen, and Mr. Broun of Georgia) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend the Controlled Substances Act to exclude therapeutic hemp and cannabidiol from the definition of marihuana, and for other purposes.
This Act may be cited as the
Charlotte’s Web Medical Hemp Act of 2014
Exclusion of therapeutic hemp and cannabidiol from definition of marihuana
Section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ) is amended in paragraph (16)—
(16) The and inserting
(16)(A) The; and
by adding at the end the following:
Therapeutic hemp and cannabidiol—
are excluded from the definition of marihuana under subparagraph (A); and
shall not be treated as controlled substances under this Act.
Section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ), as amended, is further amended by adding at the end the following:
The term ‘therapeutic hemp’ means the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.
The term cannabidiol means the substance cannabidiol, as derived from therapeutic hemp.
Non-Applicability of Federal Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. ) shall not apply to therapeutic hemp or cannabidiol as those terms are defined in section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ) as amended by this Act.
Nothing in this Act shall prohibit or otherwise restrict any activities related to the use, production, or distribution of marijuana in a State in which such activities are legal under State law.